Versanis Bio
Bimagrumab, a monoclonal antibody targeting activin type II receptor (ActRII) for obesity and metabolic disease treatment
- Sector
- Biotech
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 15 pending
Capital timeline
No federal awards or Form D filings are on record for this company.
Many early companies raise without filing a Form D, or have not yet won a federal award. New records appear here as the sources update.
Checked: SEC EDGAR Form D through Oct 23, 2026; SBIR and STTR awards through Oct 21, 2026; USAspending contract awards
Founder? Add funding contextFounders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 0 granted of 15- PendingActrii Antibody Fixed Unit Dose TreatmentsUSPTOApplication 19105371
- PendingActrii Antibody TreatmentsUSPTOApplication 18776590
- PendingCombination TherapiesUSPTOApplication 18587617
Show all 15 patent records
- Actrii Antibody Fixed Unit Dose TreatmentsMar 12, 2026 · Application 19105371Pending
- Actrii Antibody TreatmentsNov 7, 2024 · Application 18776590Pending
- Combination TherapiesOct 3, 2024 · Application 18587617Pending
- Actrii Antibody Fixed Unit Dose TreatmentsApplication PCTUS2023072982Pending
- Actrii Antibody TreatmentsApplication PCTUS2023060932Pending
- Actrii Antibody Fixed Unit Dose TreatmentsApplication 63378128Pending
- Actrii Antibody Unit Dose TreatmentsApplication 63373684Pending
- Actrii Antibody TreatmentsApplication 63373676Pending
- Combination TherapiesApplication PCTUS2022075545Pending
- Combination TherapiesApplication 63333351Pending
- Actrii Antibody TreatmentsApplication 63301011Pending
- Combination TherapiesApplication 63301012Pending
- Combination TherapiesApplication 63238068Pending
- Actrii Antibodies With Extended Half LifeApplication PCTUS2025016535Pending
- Actrii Antibodies With Extended Half LifeApplication 63559115Pending
Related companies, and why
- Petragen, Inc.Similar federal contract value in Biotech · null in contracts
- BioPhoundry, Inc.Similar federal contract value in Biotech · null in contracts
- NeuroInitiative, LLCSimilar federal contract value in Biotech · null in contracts
- Accuronix Therapeutics IncSimilar federal contract value in Biotech · null in contracts
- GENE SOLUTIONS LLCSimilar federal contract value in Biotech · null in contracts
- Fedora Pharmaceuticals Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .